%	O
%	O
TITLE	O

Association	O
between	O
oropharyngeal	O
cancers	O
with	O
known	O
HPV	O
and	O
p16	O
status	O
and	O
cervical	O
intraepithelial	O
neoplasia	O
:	O
a	O
Danish	O
population	O
-	O
based	O
study	O
.	O

%	O
%	O
ABSTRACT	O

Persistent	O
infection	O
with	O
high	O
-	O
risk	O
genotypes	O
of	O
human	O
papillomavirus	O
(	O
HPV	O
)	O
is	O
the	O
main	O
risk	O
factor	O
in	O
the	O
development	O
of	O
uterine	O
cervical	O
precancerous	O
lesions	O
and	O
cervical	O
cancer	O
(	O
CC	O
)	O
,	O
and	O
cases	O
of	O
HPV	O
-	O
induced	O
oropharyngeal	O
squamous	O
cell	O
carcinoma	O
(	O
OPSCC	O
)	O
is	O
increasing	O
in	O
the	O
Western	B-Study_Location
world	I-Study_Location
.	I-Study_Location

We	O
investigated	O
the	O
association	O
between	O
HPV	O
and	O
p16	O
status	O
and	O
previous	O
results	O
of	O
cervical	O
examinations	O
,	O
including	O
cytological	O
and	O
histological	O
tests	O
,	O
in	O
females	O
with	O
OPSCC	O
.	O
We	O
included	O
females	B-Study_Cohort
diagnosed	I-Study_Cohort
with	I-Study_Cohort
an	I-Study_Cohort
OPSCC	I-Study_Cohort
in	O
Eastern	B-Study_Location
Denmark	I-Study_Location
from	O
2000	B-Study_Time
to	I-Study_Time
2014	I-Study_Time
.	O

OPSCCs	O
were	O
assessed	O
for	O
p16	O
-	O
overexpression	O
and	O
HPV	B-HPV_Lab_Technique
DNA	I-HPV_Lab_Technique
PCR	I-HPV_Lab_Technique
.	O

History	O
of	O
cervical	O
tests	O
was	O
obtained	O
from	O
the	O
Danish	O
Pathology	O
Registry	O
.	O

The	O
cytology	O
and	O
histological	O
results	O
were	O
categorized	O
in	O
accordance	O
with	O
the	O
2014	O
Bethesda	O
System	O
(	O
TBS	O
)	O
and	O
WHO	O
.	O

Hence	O
,	O
we	O
divide	O
the	O
cervical	O
results	O
into	O
two	O
groups	O
.	O

Group	O
I	O
were	O
negative	O
for	O
intraepithelial	O
lesion	O
or	O
malignancy	O
and	O
group	O
II	O
had	O
epithelial	O
cell	O
abnormalities	O
and	O
subdivided	O
after	O
increasingly	O
neoplastic	O
severity	O
from	O
A	O
-	O
D	O
.	O

ChiA	O
total	O
of	O
417	O
women	O
with	O
OPSCC	O
were	O
identified	O
;	O
203	O
with	O
HPV	O
-	O
positive	O
tumors	O
(	O
49	O
%	O
)	O
of	O
which	O
cervical	O
cytology	O
or	O
histology	O
were	O
available	O
in	O
172	O
women	O
(	O
85	O
%	O
)	O
.	O

Among	O
these	O
,	O
22	O
(	O
13	O
%	O
)	O
patients	O
had	O
a	O
cervical	O
history	O
ofâ€‰â‰¥â€‰IIC	O
.	O

A	O
total	O
of	O
171	O
out	O
of	O
214	O
women	O
in	O
the	O
HPV	O
-	O
negative	O
group	O
(	O
80	O
%	O
)	O
were	O
examined	O
with	O
cytology	O
and	O
17	O
had	O
a	O
history	O
ofâ€‰â‰¥â€‰IIC	O
.	O

No	O
significant	O
difference	O
in	O
diagnoses	O
of	O
(	O
pre	O
)	O
cancerous	O
lesions	O
between	O
the	O
OPSCC	O
HPV	O
-	O
positive	O
and	O
negative	O
groups	O
were	O
observed	O
(	O
Ï‡HPV	O
status	O
in	O
oropharyngeal	O
tumors	O
was	O
not	O
correlated	O
with	O
a	O
history	O
ofâ€‰â‰¥â€‰IIC	O
in	O
cervical	O
examinations	O
.	O

The	O
effect	O
on	O
cervical	O
dysplasia	O
may	O
be	O
masked	O
by	O
a	O
higher	O
incidence	O
of	O
smoking	O
among	O
the	O
OPSCC	O
HPV	O
-	O
negative	O
group	O
.	O

%	O
%	O
MATERIAL	O
AND	O
METHODS	O

Study	O
population	O

All	O
female	B-Study_Cohort
patients	I-Study_Cohort
diagnosed	I-Study_Cohort
with	I-Study_Cohort
OPSCC	I-Study_Cohort
in	O
Eastern	B-Study_Location
Denmark	I-Study_Location
from	O
2000	B-Study_Time
to	I-Study_Time
2014	I-Study_Time
were	O
included	O
[	O
,	O
]	O
.	O

Patients	O
were	O
identified	O
through	O
the	O
Danish	O
Head	O
and	O
Neck	O
Cancer	O

CONTACT	O
Christian	O
von	O
Buchwald	O
Department	O
of	O
Otorhinolaryngology	O
,	O
Head	O
and	O
Neck	O
Surgery	O
and	O
Audiology	O
,	O
Rigshospitalet	O
,	O
University	O
of	O
Copenhagen	O
,	O
F2073	O
,	O
Blegdamsvej	O
9	O
,	O
2100	O
Copenhagen	O
,	O
Denmark	B-Study_Location

Supplemental	O
data	O
for	O
this	O
article	O
can	O
be	O
accessed	O
.	O

©	O
2019	O
Acta	O
Oncologica	O
Foundation	O

268	O
J	O
.	O

T	O
.	O

CHRISTENSEN	O
ET	O
AL	O
.	O

(	O
DAHANCA	O
)	O
Database	O
and	O
in	O
the	O
Danish	O
Pathology	O
Register	O
(	O
DPR	O
)	O
.	O

The	O
DAHANCA	O
database	O
collects	O
information	O
from	O
date	O
of	O
diagnosis	O
to	O
follow	O
-	O
up	O
on	O
patients	O
with	O
head	O
and	O
neck	O
cancer	O
.	O

The	O
DPR	O
holds	O
data	O
reported	O
by	O
all	O
pathology	O
departments	O
through	O
an	O
online	O
,	O
real	O
-	O
time	O
system	O
,	O
on	O
all	O
cyto	O
-	O
logical	O
and	O
histological	O
examinations	O
performed	O
in	O
Denmark	O
.	O

Registration	O
is	O
mandatory	O
by	O
law	O
.	O

The	O
population	O
was	O
identi	O
-	O
fied	O
using	O
the	O
computerized	O
Civil	O
Registration	O
System	O
which	O
provides	O
all	O
Danish	O
residents	O
with	O
a	O
unique	O
personal	O
identifi	O
-	O
cation	O
number	O
(	O
PIN	O
)	O
[	O
]	O
.	O

The	O
PIN	O
is	O
used	O
in	O
all	O
national	O
regis	O
-	O
ters	O
and	O
allowed	O
accurate	O
merging	O
between	O
the	O
two	O
nationwide	O
Danish	O
registries	O
described	O
above	O
.	O

Further	O
,	O
all	O
patient	O
characteristics	O
,	O
including	O
smoking	O
history	O
and	O
clinical	O
outcome	O
were	O
obtained	O
from	O
the	O
patient	O
files	O
.	O

HPV	O
DNA	O
analyses	O
and	O
p16	O
immunohistochemistry	O
of	O
OPSCC	O

Expert	O
head	O
and	O
neck	O
pathologists	O
reviewed	O
histological	O
specimens	B-HPV_Sample_Type
of	O
OPSCC	O
.	O

All	O
histological	O
specimens	B-HPV_Sample_Type
were	O
assessed	O
for	O
the	O
expression	B-HPV_Lab_Technique
of	I-HPV_Lab_Technique
p16	I-HPV_Lab_Technique
using	I-HPV_Lab_Technique
immunohistochem	I-HPV_Lab_Technique
-	I-HPV_Lab_Technique
istry	I-HPV_Lab_Technique
(	I-HPV_Lab_Technique
IHC	I-HPV_Lab_Technique
)	I-HPV_Lab_Technique
on	O
the	O
tumor	O
slides	O
.	O

Tumors	O
exhibiting	O
a	O
staining	O
with	O
>	O
75	O
%	O
positive	O
tumor	O
cells	O
were	O
defined	O
as	O
p16	O
-	O
positive	O
[	O
]	O
.	O

The	O
squamous	O
cell	O
carcinoma	O
diagnosis	O
was	O
examined	O
using	O
hematoxylin	O
and	O
eosin	O
stained	O
materials	O
and	O
the	O

tumors	O
were	O
divided	O
into	O
specific	O
tonsillar	O
-	O
,	O
base	O
of	O
tongue	O

-	O
,	O
and	O
nonspecific	O
tonsillar	O
squamous	O
cell	O
carcinoma	O
(	O
STSCC	O
,	O
BSCC	O
or	O
NSTSCC	O
)	O
based	O
on	O
clinical	O
information	O
and	O
tissue	B-HPV_Sample_Type
specific	O
structures	O
[	O
]	O
.	O

HPV	O
DNA	O
analysis	O
was	O
conducted	O
on	O
the	O
formalin	O
-	O
fixed	O
paraffin	O
-	O
embedded	O
(	O
FFPE	O
)	O
tumor	O
speci	B-HPV_Sample_Type
-	I-HPV_Sample_Type
mens	I-HPV_Sample_Type
as	O
previously	O
described	O
[	O
,	O
]	O
.	O

In	O
this	O
study	O
,	O
only	O
patients	O
with	O
OPSCC	O
that	O
had	O
positive	O
HPV	O
DNA	O
and	O
p16	B-HPV_Lab_Technique
IHC	I-HPV_Lab_Technique

overexpression	O
were	O
categorized	O
as	O
HPV	O
positive	O
and	O
all	O
patients	O
either	O
HPVþ	O
/	O
p16	O
-	O
,	O
HPV	O
-	O
/	O
p16þ	O
or	O
HPV	O
-	O
/	O
p16	O
-	O
are	O
referred	O
to	O
as	O
HPV	O
negative	O
(	O
n	O
214	O
)	O
[	O
]	O
.	O

Women	O
with	O
an	O
unknown	O
HPV	O
/	O
p16	O
status	O
,	O
these	O
were	O
excluded	O
.	O

Cervical	O
cancer	O
screening	O

Current	O
guidelines	O
from	O
2012	O
in	O
Denmark	B-Study_Location
recommends	O
screening	O
for	O
cervical	O
cancer	O
every	O
three	O
years	O
for	O
women	O
aged	O
23–49	O
years	O
,	O
every	O
five	O
years	O
for	O
women	O
aged	O
50–59	O
years	O
and	O
terminating	O
at	O
60–64	O
years	O
of	O
age	O
following	O
a	O
nor	O
-	O
mal	O
HPV	O
test	O
[	O
]	O
.	O

The	O
DPR	O
contains	O
information	O
on	O
dates	O
and	O
results	O
from	O
all	O
opportunistic	O
and	O
organized	O
cervical	O
cytologies	O
,	O
as	O
well	O
as	O
all	O
histologies	O
performed	O
,	O
and	O
serves	O
as	O
the	O
administrative	O
system	O
for	O
women	O
attending	O
the	O
cervical	O
screening	O
program	O
[	O
]	O
.	O

Structurally	O
,	O
the	O
DPR	O
is	O
based	O
on	O
the	O
Danish	O
version	O
of	O
Systematized	O
Nomenclature	O
of	O
Medicine	O
(	O
SNOMED	O
)	O
[	O
]	O
.	O

We	O
have	O
retrieved	O
information	O
by	O
cross	O
-	O
refer	O
-	O
encing	O
each	O
unique	O
patient	O
PIN	O
and	O
specific	O
SNOMED	O
codes	O
to	O
determine	O
the	O
number	O
of	O
screenings	O
and	O
degree	O
of	O
cer	O
-	O
vical	O
dysplasia	O
before	O
diagnosis	O
of	O
OPSCC	O
.	O

Cervical	O
cytology	O
were	O
categorized	O
according	O
to	O
the	O
2014	O
Bethesda	O
System	O
(	O
TBS	O
)	O
[	O
,	O
]	O
and	O
the	O
histological	O
test	O
were	O
categorized	O
according	O
to	O
the	O
WHO	O
[	O
]	O
.	O

Women	O
with	O
more	O
than	O
one	O
epi	O
-	O
sode	O
of	O
cervical	O
lesions	O
were	O
included	O
only	O
once	O
with	O
the	O
worst	O
diagnosis	O
.	O

We	O
divided	O
cervical	O
cytology	O
and	O

histological	O
examinations	O
into	O
group	O
I	O
(	O
negative	O
for	O
intraepi	O
-	O
thelial	O
lesion	O
or	O
malignancy	O
)	O
and	O
group	O
II	O
(	O
epithelial	O
cell	O
abnormalities	O
)	O
.	O

Group	O
II	O
where	O
subdivided	O
into	O
four	O
sub	O
-	O
groups	O
(	O
A	O
-	O
D	O
)	O
with	O
increasingly	O
neoplastic	O
severity	O
as	O
illus	O
-	O
trated	O
in	O
.	O

Statistical	O
analysis	O

Statistical	O
analyses	O
were	O
performed	O
in	O
R	O
version	O
3	O
.	O
5	O
.	O

0	O
[	O
]	O
.	O

The	O
Pearson	O
Chi	O
-	O
square	O
test	O
was	O
used	O
to	O
compare	O
patients	O
categorized	O
as	O
HPV	O
positive	O
oropharyngeal	O
tumors	O
with	O
the	O
HPV	O
negative	O
tumors	O
,	O
to	O
evaluate	O
the	O
distribution	O
of	O
cervical	O
cytology	O
.	O

Differences	O
in	O
tumor	O
location	O
,	O
T	O
-	O
and	O
N	O
-	O
stage	O
,	O
and	O
status	O
at	O
follow	O
-	O
up	O
were	O
also	O
assessed	O
by	O
the	O
Pearson	O
Chi	O
-	O
square	O
test	O
.	O

Student	O
t	O
-	O
test	O
was	O
used	O
to	O
compare	O
cervical	O
cytology	O
/	O
histology	O
and	O
number	O
of	O
pack	O
years	O
(	O
py	O
)	O
according	O
to	O
HPV	O
status	O
including	O
95	O
%	O
confidence	O
intervals	O
(	O
95	O
%	O
CI	O
)	O
.	O

The	O
Wilcoxon	O
test	O
was	O
used	O
to	O
compare	O
median	O
age	O
.	O

In	O
cate	O
-	O
gories	O
with	O
less	O
than	O
5	O
patients	O
,	O
the	O
Fisher’s	O
exact	O
test	O
was	O
used	O
to	O
compare	O
the	O
groups	O
.	O

We	O
used	O
ordinal	O
logistic	O
regres	O
-	O
sion	O
to	O
evaluate	O
the	O
three	O
categories	O
of	O
cervical	O
examination	O
results	O
between	O
HPV	O
-	O
positive	O
and	O
–negative	O
women	O
adjusted	O
for	O
age	O
and	O
smoking	O
.	O

We	O
categorized	O
the	O
results	O
of	O
cervical	O
examinations	O
into	O
group	O
I	O
-	O
IIAB	O
and	O
IICD	O
,	O
and	O
performed	O
a	O
logistic	O
regression	O
adjusted	O
for	O
age	O
and	O
smoking	O
.	O

A	O
p	O
-	O
value	O
below	O
.	O
05	O
was	O
considered	O
statistically	O
significance	O
.	O

